|
Report Date : |
28.11.2013 |
IDENTIFICATION DETAILS
|
Name : |
UNIJULES LIFE SCIENCES LIMITED |
|
|
|
|
Registered
Office : |
Shop No. 41, Manisha Plaza, Sonapur Lane, Off LBS Marg, Kurla (West),
Mumbai – 400072, Maharashtra |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2012 |
|
|
|
|
Date of
Incorporation : |
16.01.2006 |
|
|
|
|
Com. Reg. No.: |
11-158928 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs. 138.637 Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U52311MH2006PLC158928 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
MUMU04752G |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAACU8032D |
|
|
|
|
Legal Form : |
A Closely Held Public Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturer of Pharmaceuticals. |
|
|
|
|
No. of Employees
: |
Information denied by management |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (50) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 4600000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established company having a satisfactory track record. Management of the company has failed to file its financial for the
year 2013 with the government department. As per financials (2012), we found that the company has achieved
better growth in its turnover during 2012. Networth of the company appears to
be decent. Trade relations are fair. Business is active. Payment terms are
usually correct. The company can be considered for business dealings at usual trade
terms and conditions. |
NOTES :
Any query related to this report can be made on
e-mail : infodept@mirainform.com
while quoting report number, name and date.
INDIAN ECONOMIC OVERVIEW
The current downturn
provides an opportunity to push ahead with reforms to accelerate growth, says
the latest India Development Update report released by the World Bank. The
report says that the adverse effects of rupee depreciation are likely to be
offset by the gains in the exports performance due to improved external
competitiveness. Since May this year, the local currency has depreciated
substantially and fell to a record level of Rs 68.85 to a dollar on August, 28.
A stagflation like
situation appears to have arisen as inflation jumped to an eight month high of 6.46
% for the month of September. It is up from 6.10 % in August. Growth continues
to be muted with factory output plunging to 0.6 % in August. Onion prices
have risen nearly 300 % from last September. Vegetables cost nearly 90 % more
than they did last year. Wake up to the economic contribution of slum dwellers.
They contribute more than 7.5 % to the country’s gross domestic product,
according to a recent study conducted in 50 top cities.
136000 estimated
number of jobs created during the second quarter of the current financial year.
50000 estimated number of additional jobs in the field of corporate social
responsibility in the coming years.
The International
Finance Corporation expects to come out with its rupee linked bonds issue
before the end of 2013 as a part of its plan to raise $ 1 billion. The Apple
iPhone 5c (Rs 41900 for 16 GB variant) and 5s (Rs 53500 for 16GB variant) has
been launched in India from 1st November.
The Land Acquisition
Act to provide just and fair compensation to farmers will come into force from
January 1 next year, said Rural Development Minister Jairam Ramesh. The Act
replaces a 119 year old registration. The Securities and Exchange Board of
India has approved the trading of currency futures on the Bombay Stock
Exchange. The exchange plans to launch the currency futures platform with
advanced trading technology by the end of November.
EXTERNAL AGENCY RATING
|
Rating Agency Name |
CRISIL |
|
Rating |
Long Term Rating = BBB- |
|
Rating Explanation |
Having moderate degree of safety and carry moderate credit risk. |
|
Date |
24.07.2012 |
|
Rating Agency Name |
CRISIL |
|
Rating |
Short Term Rating = A3 |
|
Rating Explanation |
Moderate degree of safety and higher credit risk. |
|
Date |
24.07.2012 |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter in
the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2012.
INFORMATION DECLINED BY
|
Name : |
Mr. Narayan |
|
Designation : |
Finances Department |
|
Contact No.: |
91-7118-271010 |
|
Date : |
27.11.2013 |
LOCATIONS
|
Registered Office : |
Shop No.41, Manisha Plaza, Sonapur Lane, Off LBS Marg, Kurla (West),
Mumbai – 400072, Maharashtra, India |
|
Tel. No.: |
91-22-25035173 |
|
Fax No.: |
Not Available |
|
E-Mail : |
|
|
Website : |
|
|
Location : |
Owned |
|
|
|
|
Corporate Office / Factory: |
B – 35 and 36, MIDC Industrial Area, Kalmeshwar. District Nagpur -
441501, Maharashtra, India |
|
Tel. No.: |
91-7118-271010 |
|
Fax No.: |
91-7118-272522 |
DIRECTORS
As on 29.09.2012
|
Name : |
Mr. Faiz Zakir Vali |
|
Designation : |
Managing Director |
|
Address : |
Universal Pharmacy, Plot No. 545, Shantinagar, Nayapura , Nagpur - 440002 Maharashtra, India |
|
Date of Birth/Age : |
25.02.1967 |
|
Qualification : |
MBA. B Pharm |
|
Date of Appointment : |
25.09.2010 |
|
PAN No.: |
ABBPV9750E |
|
DIN No.: |
01809196 |
|
|
|
|
Name : |
Mr. Dharampal Keshawdas Bellani |
|
Designation : |
Whole Time Director |
|
Address : |
Block No. 371/B, Gurunanak Nagar, Jaripatka, Nagpur - 440014, Maharashtra, India |
|
Date of Birth/Age : |
30.04.1956 |
|
Qualification : |
B. Pharm |
|
Date of Appointment : |
25.09.2010 |
|
PAN No.: |
ABNPB0886F |
|
DIN No.: |
01824596 |
|
|
|
|
Name : |
Mr. Gulam Abbas Hassonjee |
|
Designation : |
Director |
|
Address : |
202, Radhe Apartment, Mecosabagh, Clark Town, Nagpur –
440004, Maharashtra, India |
|
Date of Birth/Age : |
13.04.1941 |
|
Date of Appointment : |
30.09.2013 |
|
DIN No.: |
00162445 |
|
|
|
|
Name : |
Mr. Rajeev Kawaduji Jidewar |
|
Designation : |
Whole-time director |
|
Address : |
10, Nandanvan Colony, Nagpur – 440009, Maharashtra, India |
|
Date of Birth/Age : |
03.10.1956 |
|
Date of Appointment : |
30.09.2013 |
|
DIN No.: |
00450038 |
KEY EXECUTIVES
|
Name : |
Ms. Shilpa Pawankar |
|
Designation : |
Company Secretary |
|
Address : |
Plot No. 12, Adarsh Wadi, Amaravati Road, Nagpur – 440023, Maharashtra, India |
|
Date of Birth/Age : |
12.06.1986 |
|
Date of Appointment : |
12.01.2010 |
|
Pan No.: |
BDSPP0606B |
|
|
|
|
Name : |
Mr. Narayan |
|
Designation : |
Finances Department |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on 29.09.2012
|
Names of Shareholders |
|
No. of Shares |
|
Faiz Zakir Vali |
|
8313684 |
|
Nitish Shastri |
|
2000 |
|
Esa Mohammad Vali |
|
2000 |
|
Shehrebano Vali |
|
2000 |
|
Rajeev Jidewar |
|
2000 |
|
Sharmishtha U. Khobragade |
|
2000 |
|
Astra Exim Private Limited, India |
|
2225500 |
|
Benzo Petro International Limited, India |
|
468750 |
|
Virtuous Capital Limited (Formally known as Finaventure Advisory Services (India) Limited), India |
|
2781200 |
|
Pranav Financial Services Private Limited, India |
|
64516 |
|
Total |
|
13863650 |
As on 29.09.2012
Equity Share Break up (Percentage of Total Equity)
|
Category |
Percentage |
|
Bodies corporate |
39.96 |
|
Directors or relatives of Directors |
60.00 |
|
Other top fifty shareholders |
0.04 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer of Pharmaceuticals. |
||||
|
|
|
||||
|
Products : |
|
PRODUCTION STATUS (AS ON 31.03.2011)
|
Particulars |
Unit |
Actual
Production |
|
Allopathic : |
|
|
|
Liquid (in 000) |
Ltrs |
3590191.70 |
|
Ointment |
Kgs. |
70163.72 |
|
Powder |
Kgs. |
8379.35 |
|
Capsulses ('000) |
Nos. |
10476.71 |
|
Injection : |
|
|
|
Vials/ Ampoules |
Nos |
56871415.00 |
|
Herbal : |
|
|
|
Liquid |
Ltrs |
437100.79 |
|
Tablets ('000) |
Nos. |
82037.16 |
|
Capsulses ('000) |
Nos. |
71590.77 |
|
Powder |
Kgs. |
2243211.02 |
GENERAL INFORMATION
|
No. of Employees : |
Information denied by management |
||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
|
Bankers : |
· Punjab National Bank, MID Corporate Branch, Suryanagar, Nagpur - 440035, Maharashtra, India · Axis Bank Limited, Ground Floor, Atlanta Building, Nariman Point, Mumbai - 400021, Maharashtra, India · Allahabad Bank, Civil Lines, Nagpur - 440001, Maharashtra, India · Bank of Maharashtra, Mid Corporate Branch, Mahabank Bhavan, Sitabuldi, Nagpur - 440012, Maharashtra, India · Yes Bank Limited, 9th Floor, Nehru Centre, Discovery Of India, Dr. Annie Besant Road, Worli, Mumbai - 400018, Maharashtra, India · State Bank of India, Industrial Finance Branch, World Trade Centre, Cuffe Parade, Mumbai - 400005, Maharashtra, India · The Shamrao Vithal Co-Operative Bank Limited, 39, Vrinda Kunj, Matamandir Road, Dharampeth, Nagpur - 440010, Maharashtra, India · Indusind Bank, Mumbai · HSBC BANK · Union Bank of India · Bank of Baroda ·
ICICI Bank Limited |
||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
|
Facilities : |
(Rs.
In Millions)
|
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Husain Ali Hatim Shabbir Chartered Accountants |
|
Address : |
315 B Ashirwad Complex, Ramdaspeth, Nagpur – 440012, Maharashtra, India |
|
Tel. No.: |
91-712-2420204 |
|
Fax No.: |
91-712-2420204 |
|
PAN.: |
ABCPH6547G |
|
|
|
|
Subsidiaries : |
RevAyur Beauty Care India Private Limited CIN No.: U93090MH2009PTC196258 |
|
|
|
|
Associates : |
· Akasa Advertisement · Universal Pharmacy · City Pharmacy · Saif Health Remedies Private Limited |
CAPITAL STRUCTURE
As on 29.09.2012
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
25000000 |
Equity Shares |
Rs.10/- each |
Rs.250.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
13863650 |
Equity Shares |
Rs.10/- each |
Rs.138.637
Millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
|
31.03.2012 |
31.03.2011 |
|
I.
EQUITY
AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
|
138.637 |
138.637 |
|
(b) Reserves & Surplus |
|
1035.832 |
693.413 |
|
(c) Money
received against share warrants |
|
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money pending allotment |
|
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
|
1174.469 |
832.050 |
|
|
|
|
|
|
(3)
Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
|
298.633 |
286.453 |
|
(b) Deferred tax liabilities (Net) |
|
53.887 |
23.384 |
|
(c) Other long term liabilities |
|
0.000 |
0.000 |
|
(d) long-term provisions |
|
11.244 |
7.893 |
|
Total Non-current Liabilities (3) |
|
363.764 |
317.730 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a) Short term borrowings |
|
1063.870 |
800.867 |
|
(b) Trade payables |
|
444.327 |
342.789 |
|
(c) Other current
liabilities |
|
1.536 |
0.000 |
|
(d) Short-term provisions |
|
0.000 |
0.000 |
|
Total Current Liabilities (4) |
|
1509.733 |
1143.656 |
|
|
|
|
|
|
TOTAL |
|
3047.966 |
2293.436 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a) Fixed Assets |
|
|
|
|
(i) Tangible assets |
|
844.407 |
428.333 |
|
(ii) Intangible Assets |
|
2.674 |
2.308 |
|
(iii) Capital
work-in-progress |
|
34.824 |
157.833 |
|
(iv)
Intangible assets under development |
|
0.000 |
0.000 |
|
(b) Non-current Investments |
|
19.230 |
33.636 |
|
(c) Deferred tax assets (net) |
|
0.000 |
0.000 |
|
(d) Long-term Loan and Advances |
|
0.000 |
0.000 |
|
(e) Other Non-current assets |
|
0.000 |
0.000 |
|
Total Non-Current Assets |
|
901.135 |
622.110 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a) Current investments |
|
0.000 |
0.000 |
|
(b) Inventories |
|
373.044 |
308.766 |
|
(c) Trade receivables |
|
1337.953 |
1071.959 |
|
(d) Cash and cash
equivalents |
|
28.464 |
103.651 |
|
(e) Short-term loans and
advances |
|
388.060 |
171.652 |
|
(f) Other current assets |
|
19.310 |
1.298 |
|
Total Current Assets |
|
2146.831 |
1657.326 |
|
|
|
|
|
|
TOTAL |
|
3047.966 |
2293.436 |
|
SOURCES OF FUNDS |
|
|
31.03.2010 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
|
|
138.637 |
|
|
2] Share Application Money |
|
|
0.000 |
|
|
3] Reserves & Surplus |
|
|
481.935 |
|
|
4] (Accumulated Losses) |
|
|
0.000 |
|
|
NETWORTH |
|
|
620.572 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
|
|
211.348 |
|
|
2] Unsecured Loans |
|
|
1.378 |
|
|
TOTAL BORROWING |
|
|
212.726 |
|
|
DEFERRED TAX LIABILITIES |
|
|
20.303 |
|
|
|
|
|
|
|
|
TOTAL |
|
|
853.601 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
|
|
298.132 |
|
|
Capital work-in-progress |
|
|
38.089 |
|
|
|
|
|
|
|
|
INVESTMENT |
|
|
30.616 |
|
|
DEFERREX TAX ASSETS |
|
|
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
|
|
304.922 |
|
|
Sundry Debtors |
|
|
694.667 |
|
|
Cash & Bank Balances |
|
|
16.270 |
|
|
Other Current Assets |
|
|
0.000 |
|
|
Loans & Advances |
|
|
279.545 |
|
Total
Current Assets |
|
|
1295.404 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
|
|
193.828 |
|
|
Other Current Liabilities |
|
|
537.044 |
|
|
Provisions |
|
|
78.863 |
|
Total
Current Liabilities |
|
|
809.735 |
|
|
Net Current Assets |
|
|
485.669 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
|
|
1.095 |
|
|
|
|
|
|
|
|
TOTAL |
|
|
853.601 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2012 |
31.03.2011 |
31.03.2010 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
3668.373 |
2661.848 |
1982.636 |
|
|
|
Other Income |
72.581 |
27.418 |
1.138 |
|
|
|
TOTAL |
3740.954 |
2689.266 |
1983.774 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Cost of materials consumed |
2989.871 |
2243.364 |
1530.006 |
|
|
|
Changes in inventories of finished goods, work-in-progress and stock-in-trade |
(55.435) |
(113.264) |
38.003 |
|
|
|
Employee benefit expense |
93.142 |
46.528 |
98.552 |
|
|
|
Other expenses |
134.626 |
107.447 |
3.586 |
|
|
|
Exceptional items |
(64.826) |
0.000 |
|
|
|
|
TOTAL |
3097.378 |
2284.075 |
1688.862 |
|
|
|
|
|
|
|
|
Less |
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION |
643.576 |
405.191 |
294.912 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
149.642 |
89.283 |
71.424 |
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION |
493.934 |
315.908 |
223.488 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
23.177 |
16.003 |
11.219 |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX |
470.757 |
299.905 |
212.178 |
|
|
|
|
|
|
|
|
|
Less |
TAX |
128.338 |
88.428 |
86.014 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
|
342.419 |
211.477 |
126.164 |
|
|
|
|
|
|
|
|
|
Add |
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD |
512.949 |
301.472 |
175.308 |
|
|
|
|
|
|
|
|
|
|
BALANCE CARRIED
TO THE B/S |
855.368 |
512.949 |
301.472 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
24.70 |
15.26 |
9.39 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2012 |
31.03.2011 |
31.03.2010 |
|
PAT / Total Income |
(%) |
9.15
|
7.86 |
6.36 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
12.83
|
11.27 |
10.70 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
15.72
|
14.36 |
13.31 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.40
|
0.36 |
0.34 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Debt /Networth) |
|
1.16
|
1.31 |
0.34 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.42
|
1.45 |
1.60 |
LOCAL AGENCY FURTHER INFORMATION
CURRENT MATURITIES OF
LONG-TERM DEBT: NOT AVAILABLE
|
Sr. No. |
Check List by Info
Agents |
Available in Report (Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
No |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
Yes |
|
8] |
No. of employees |
Yes |
|
9] |
Name of person contacted |
Yes |
|
10] |
Designation of contact person |
Yes |
|
11] |
Turnover of firm for last three years |
Yes |
|
12] |
Profitability for last three years |
Yes |
|
13] |
Reasons for variation <> 20% |
---------------------- |
|
14] |
Estimation for coming financial year |
No |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister concerns |
Yes |
|
17] |
Major suppliers |
No |
|
18] |
Major customers |
No |
|
19] |
Payments terms |
No |
|
20] |
Export / Import details (if applicable) |
No |
|
21] |
Market information |
---------------------- |
|
22] |
Litigations that the firm / promoter involved in |
---------------------- |
|
23] |
Banking Details |
Yes |
|
24] |
Banking facility details |
Yes |
|
25] |
Conduct of the banking account |
---------------------- |
|
26] |
Buyer visit details |
---------------------- |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if applicable |
Yes |
|
29] |
Last accounts filed at ROC |
No |
|
30] |
Major Shareholders, if available |
Yes |
|
31] |
Date of Birth of Proprietor/Partner/Director, if available |
Yes |
|
32] |
PAN of Proprietor/Partner/Director, if available |
Yes |
|
33] |
Voter ID No of Proprietor/Partner/Director, if available |
No |
|
34] |
External Agency Rating, if available |
Yes |
YEAR IN RETROSPECT:
The company has repeated its winning streak of clocking 37.79% incremental growth in the last year’s. The Company has achieved a total sale of Rs.3665.390 Millions (net of excise) as against Rs.2660.030 Millions (net of excise) for the same period in the last year. The Company has achieved a net profit of Rs.342.419 Millions (After provision of tax) as against Rs.211.477 Millions for the same period in the last year registering an increase of 61.80%.
BUSINESS OUTLOOK:
Some of the major milestones crossed during the year were,
INSTITUTIONAL BUSINESS remains a major thrust area looking to the huge national budget and the company’s historical expertise in this segment. During the year, we successfully participated in bulk tenders to cater to increased capacities thereby achieving the targeted growth milestones.
RESEARCH AND DEVELOPMENT infrastructure was recognized as PhD Centre by the university which opens the gate way for doing the best research and retaining the best researchers in the company thus generating the new technologies and the products.
THE INTELLECTUAL PROPERTY INITIATIVE resulted in filing of 24 filled patents which are under different stages of the evaluation by the WIPO. These patents include various progress done on standardization of herbal and Ayurvedic plants and formulations
PUBLISHED 10 research papers in this year in different national and international journals which is proving to help us in registration of these products in different countries.
Overall INTERNATIONAL FOOTPRINT increased to cover ASEAN, CIS and neighboring countries with various dossiers filed for registration. Commercialized more than 80 products which found its reach in different countries.
On the PRODUCT PIPELINE FRONT, development work progressed as per plan on the technologies related to NDDS. Further, new technologies identified and the work started on like cooling gel sheets, liquid in hard gelatin capsule forms.
The CLINICAL TRIALS of 4 of our herbal products will be completed in October, 2012. Good work done in the field of herbal remedy for sickle cell anemia with on field trials under progress.
ETHICAL SALES DIVISION increased its footprint in existing states by increasing the number of Head Quarters and Field force resulting in increase of 75 % over last year. Addition of Novel high margin products increased the overall yield from this segment. REVAYUR continues on its growth trajectory by sing novel ways of brand development including a tie up with FEMINA group for publicity. The number of different SKU’s also increased to cover the professional Beauty parlors as well as launch of a Hair Care range of Products. There is increased interest for this beauty care range on the international front and will be a key result area in the coming years. HERBULES product range continues to expand almost doubling the sales. Current plans are to increase the market reach of this range of products. Tremendous response for these products from Bangladesh, CIS and UAE markets.
On the management and infrastructure front,
Integrated common ERP platform has been successfully implemented on line across all locations resulting in improved reporting and efficiency in operations. Combined H.R. department established for uniform implementation of policies across the group. New herbal facility attained full commercial production resulting in increased revenues from the herbal segment. Efficiency audits conducted at the injectable plant thus improving productivity by 23 % without any capital expenses.
UNSECURED LOAN
Rs. In Millions
|
Particular |
As
on 31.03.2012 |
As
on 31.03.2011 |
|
Short-term
borrowings |
|
|
|
Loans repayable on demand from others |
9.898 |
0.000 |
|
Loans and advances from others |
35.650 |
27.946 |
|
Total |
45.548 |
27.946 |
|
|
|
|
INDEX OF CHARGES
|
S.No. |
Charge ID |
Date of Charge
Creation/Modification |
Charge amount
secured |
Charge Holder |
Address |
Service Request
Number (SRN) |
|
1 |
10427281 |
26/03/2013 |
480,000,000.00 |
PUNJAB NATIONAL BANK |
MID CORPORATE BRANCH, SURYANAGAR, NAGPUR, MAHARASHTRA - 440035, INDIA |
B75672410 |
|
2 |
10376918 |
17/09/2012 |
100,000,000.00 |
YES BANK LIMITED |
9TH FLOOR, NEHRU CENTRE, DISCOVERY OF INDIA,
DR. ANNIE BESANT ROAD, WORLI, MUMBAI, MAHARASHTRA - |
B58276841 |
|
3 |
10377122 |
16/11/2012 * |
430,000,000.00 |
BANK OF MAHARASHTRA |
MID CORPORATE BRANCH, MAHABANK BHAVAN, SITABULDI, |
B62804463 |
|
4 |
10356491 |
28/03/2012 |
42,500,000.00 |
STATE BANK OF INDIA |
INDUSTRIAL FINANCE BRANCH, WORLD TRADE CENTRE, CUFFE PARADE, MUMBAI, MAHARASHTRA - 400005, INDIA |
B39904537 |
|
5 |
10351320 |
02/03/2012 |
400,000.00 |
STATE BANK OF INDIA |
ITWARI BRANCH, NAGPUR, MAHARASHTRA - 440002, INDIA |
B38055968 |
|
6 |
10332807 |
03/04/2012 * |
297,900,000.00 |
STATE BANK OF INDIA |
INDUSTRIAL FINANCE BRANCH, WORLD TRADE CENTRE, CUFFE PARADE, MUMBAI, MAHARASHTRA - 400005, INDIA |
B39917398 |
|
7 |
10327684 |
03/04/2012 * |
1,101,000,000.00 |
STATE BANK OF INDIA |
INDUSTRIAL FINANCE BRANCH, WORLD TRADE CENTRE, CUFFE PARADE, MUMBAI, MAHARASHTRA - 400005, INDIA |
B39917034 |
|
8 |
10318293 |
05/11/2011 |
350,000.00 |
THE SHAMRAO VITHAL CO-OPERATIVE BANK LIMITED |
SVC TOWER, NEHRU ROAD, VAKOLA, SANTACRUZ (EAST), |
B25572587 |
|
9 |
10318325 |
22/10/2011 |
622,000.00 |
THE SHAMRAO VITHAL CO-OPERATIVE BANK LIMITED |
SVC TOWER, NEHRU ROAD, VAKOLA, SANTACRUZ (EAST), |
B25580515 |
|
10 |
10313419 |
05/10/2011 |
715,000.00 |
SHAMRAO VITHAL CO-OPERATIVE BANK LIMITED |
SVC TOWER, NEHRU ROAD, VAKOLA, SANTACRUZ (EAST), |
B23625031 |
|
11 |
10305188 |
19/07/2011 |
300,000,000.00 |
BANK OF BARODA |
CORPORATE FINANCIAL SERVICES BRANCH, MANTRI COURT, 1ST FLOOR, 39 RAMABAI AMBEDKAR ROAD, PUNE, MAHARASHTRA - 411001, INDIA |
B20021085 |
|
12 |
10290108 |
25/02/2013 * |
322,500,000.00 |
ALLAHABAD BANK |
CIVIL LINES,, NAGPUR, MAHARASHTRA - 440001, INDIA |
B76666726 |
|
13 |
10273049 |
04/02/2011 |
41,600,000.00 |
STATE BANK OF INDIA |
ITWARI BRANCH, ITWARI, NAGPUR, MAHARASHTRA - 440002, INDIA |
B07059652 |
|
14 |
10273029 |
04/02/2011 |
692,500,000.00 |
STATE BANK OF INDIA |
ITWARI BRANCH, ITWARI, NAGPUR, MAHARASHTRA - 4400 |
B06939730 |
|
15 |
10307948 |
25/01/2011 |
692,500,000.00 |
STATE BANK OF INDIA |
ITWARI BRANCH, ITWARI, NAGPUR, MAHARASHTRA - 440002, INDIA |
B09530320 |
|
16 |
10346163 |
22/11/2010 |
317,000.00 |
THE SHAMRAO VITHAL CO-OPERATIVE BANK LIMITED |
39, VRINDA KUNJ, MATAMANDIR ROAD, DHARAMPETH, NAGPUR, MAHARASHTRA - 440010, INDIA |
B30914006 |
|
17 |
10346161 |
11/11/2010 |
1,462,400.00 |
THE SHAMRAO VITHAL CO-OPERATIVE BANK LIMITED |
39, VRINDA KUNJ, MATAMANDIR ROAD, DHARAMPETH, NAGPUR, MAHARASHTRA - 440010, INDIA |
B30912802 |
|
18 |
10234487 |
31/05/2010 |
872,500,000.00 |
AXIS BANK LIMITED |
UNIT NO 6 ,CREDIT MANAGEMENT CENTRE, CORPORATE PARK, CHEMBUR, MUMBAI, MAHARASHTRA - 400071, INDIA |
A89810055 |
|
19 |
10294689 |
31/03/2010 |
180,000,000.00 |
STATE BANK OF INDIA |
ITWARI BRANCH, NAGPUR, MAHARASHTRA - 440002, INDIA |
A92558139 |
|
20 |
10169305 |
31/05/2010 * |
680,302,000.00 |
AXIS BANK LIMITED |
UNIT NO 6 ,CREDIT MANAGEMENT CENTRE, CORPORATE PARK, CHEMBUR, MUMBAI, MAHARASHTRA - 400071, INDIA |
A89811087 |
|
21 |
10164122 |
21/01/2010 * |
552,500,000.00 |
AXIS BANK LIMITED |
GROUND FLOOR,ATLANTA BLD, NARIMAN POINT, MUMBAI, MAHARASHTRA - 400021, INDIA |
A80677834 |
|
22 |
10121132 |
31/07/2008 |
440,302,000.00 |
THE SHAMRAO VITHAL CO-OP. BANK LIMITED. |
YAMUNA SADAN, SAKI VIHAR ROAD, SAKINAKA, ANDHERI |
A45172210 |
|
23 |
10072672 |
31/07/2008 * |
440,302,000.00 |
THE SHAMRAO VITHAL CO-OP. BANK LIMITED. |
YAMUNA SADAN, SAKI VIHAR ROAD,, SAKINAKA, ANDHERI |
A45171758 |
|
24 |
10074903 |
04/09/2006 |
27,050,000.00 |
THE SHAMRAO VITHAL CO-OP. BANK LIMITED. |
YAMUNA SADAN, SAKI VIHAR ROAD, SAKINAKA, ANDHERI (EAST), MUMBAI, MAHARASHTRA - 400072, INDIA |
A08154445 |
|
25 |
80017269 |
31/07/2008 * |
440,302,000.00 |
THE SHAMRAO VITHAL CO-OP. BANK LIMITED. |
YAMUNA SADAN, SAKI VIHAR ROAD,, SAKINAKA, ANDHERI |
A45190766 |
* Date of charge modification
FIXED ASSETS
· Land
· Factory Building
· Plant and Machinery
· AHU
· Electric Installation
· Laboratory Equipments
· Office Equipments
· Computer Accessories
· E.P.A.B.X.
· Vehicles
· Furniture and Fixture
· Borwell
· Canteen Utensils
· Trade Mark
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners, controlling
shareholders or senior officers as terrorist or terrorist organization or whom
notice had been received that all financial transactions involving their assets
have been blocked or convicted, found guilty or against whom a judgement or
order had been entered in a proceedings for violating money-laundering,
anti-corruption or bribery or international economic or anti-terrorism sanction
laws or whose assets were seized, blocked, frozen or ordered forfeited for
violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No exist to suggest that subject is or was
the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper payments
to government officials for engaging in prohibited transactions or with
designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.62.36 |
|
|
1 |
Rs.101.11 |
|
Euro |
1 |
Rs.84.68 |
INFORMATION DETAILS
|
Information
Gathered by : |
PDT |
|
|
|
|
Report Prepared
by : |
NTH |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
4 |
|
PAID-UP CAPITAL |
1~10 |
4 |
|
OPERATING SCALE |
1~10 |
6 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
6 |
|
--PROFITABILIRY |
1~10 |
6 |
|
--LIQUIDITY |
1~10 |
6 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
7 |
|
--CREDIT LINES |
1~10 |
6 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
DEFAULTER |
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
50 |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.